June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Retinoids improvements during the treatment by human amniotic membrane of corneal alkali burns in a mouse model
Author Affiliations & Notes
  • Nicolas Bonnin
    Ophthalmology, Gabriel Montpied Hospital, Clermont-Ferrand, France
    R2D2 EA7281, Auvergne University, Clermont-Ferrand, France
  • Loic Blanchon
    R2D2 EA7281, Auvergne University, Clermont-Ferrand, France
  • Corinne Belville
    R2D2 EA7281, Auvergne University, Clermont-Ferrand, France
    GRED INSERM 1103, Auvergne University, Clermont-Ferrand, France
  • Georges Souteyrand
    Ophthalmology, Gabriel Montpied Hospital, Clermont-Ferrand, France
  • Frederic Chiambaretta
    Ophthalmology, Gabriel Montpied Hospital, Clermont-Ferrand, France
    R2D2 EA7281, Auvergne University, Clermont-Ferrand, France
  • Vincent Sapin
    R2D2 EA7281, Auvergne University, Clermont-Ferrand, France
  • Footnotes
    Commercial Relationships Nicolas Bonnin, None; Loic Blanchon, None; Corinne Belville, None; Georges Souteyrand, None; Frederic Chiambaretta, None; Vincent Sapin, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3870. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nicolas Bonnin, Loic Blanchon, Corinne Belville, Georges Souteyrand, Frederic Chiambaretta, Vincent Sapin; Retinoids improvements during the treatment by human amniotic membrane of corneal alkali burns in a mouse model. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3870.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The aim of this study is to establish the effects of a human amniotic membrane (HAM) treatment by retinoids (active derivatives of vitamin A); just before its graft on a corneal alkali burn using a mouse model.

Methods: This protocol was approved by the regional ethic committee (CEMEA Auvergne). Thirty eyes of male mice, dispatched into 5 groups: the first group was untreated, the others received a treatment by HAM grafts prepared according to four different conditions and one control: non cultivated (control group), cultivated during 24 hours in a standard culture medium, cultivated in a culture medium containing all-trans retinoic acid (ATRA) dissolved in dimethylsulfoxide (DMSO) and cultivated in a culture medium containing DMSO. Induction of HAM by ATRA was assessed by PCR quantification of RARβ (already published as a gene induced by retinoids). The photographs evaluated corneal re-epithelialization, histopathology evaluated ulceration depth, immunohistochemical analysis and signal quantification numbered the expression of MMP9 and VEGF.

Results: For the ulcers surface, we noted a significant difference between the groups HAM cultivated during 24 hours without or with ATRA compared to the untreated group; and any significant difference between the group HAM cultivated in a medium containing DMSO and the untreated group. Concerning the ulcers depth, there was a significant difference between the group treated by HAM cultivated 24 hours with ATRA compared to the untreated group. Immunohistochemistry assays showed that MMP 9 and VEGF expression were decreased in the groups treated with HAM cultivated during 24 hours with ATRA compared to the other groups.

Conclusions: The positive effects of HAM culture show its biological effect more than its mechanical effect. DMSO appears to reduce the effect of ATRA, implying quickly the use of a new non-toxic vector for clinical applications. Nevertheless, our results clearly showed that the induction of MAH by ATRA appears to have a beneficial effect on the ulcers depth and the expression of MMP 9 and VEGF. Our preliminary results are really promising in order to propose a positive engineering of HAM applied for wound healing graft on cornea in the next future.

Keywords: 480 cornea: basic science • 765 wound healing • 554 immunohistochemistry  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×